Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
522.00    -3.00 (-0.57%)
Bid:
524.00
Ask:
526.00
Spread: 2.00 (0.382%)
Market Cap: £512.62m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Trading Statement

22 May 2018 07:00

RNS Number : 7946O
Galliford Try PLC
22 May 2018
 

GALLIFORD TRY PLC

 

TRADING UPDATE

TUESDAY 22 MAY 2018

 

Galliford Try plc, the housebuilding and construction group, today issues its trading update for the period 1 January to 21 May 2018. All data is as at 18 May 2018, unless otherwise stated, and all comparable figures relate to the prior year equivalent period.

 

Peter Truscott, Chief Executive:

 

"The Group continues to deliver a strong operational and financial performance and is making good progress against its growth plans to 2021. Following the successful completion of the recent rights issue the Group is well capitalised with a strengthened balance sheet to support our planned growth.

 

In Linden Homes sales rates remain encouraging at 0.71 units per site per week since 1 January, positioning the business well for the remainder of the financial year. We are also making good progress in line with our strategic objectives, and expect to report further margin improvement.

 

Partnerships & Regeneration continues to benefit from strong demand and opportunity to grow both its mixed tenure and contracting offering. The business expects to report margin growth driven by market demand, contract wins and our successful geographical expansion.

 

On the Aberdeen Western Peripheral Route we are making good progress on site, with progressive handover of sections of road under way. We have experienced some further cost pressure, principally from weather delays, which are likely to increase the exceptional charge in the current year. The amount will depend upon progress recovered through the summer, and is expected to be lower than the charge (£25m) taken in the first half. We are continuing to discuss several significant claims. Practical completion of the project is anticipated this summer.

 

Construction's underlying performance continues to improve, while continuing to work through diminishing outstanding legacy contracts. The business is seeing a good level of new project wins and opportunities on its multiple frameworks, whilst maintaining its disciplined approach to bidding.

 

Cash continues to be well managed, and average net debt has been below the guided figure of £275m (excluding the additional cash raised).

 

The Group's operating outlook is unchanged and all three businesses remain on track to deliver further profitable growth over the full year. We anticipate achieving a full year result in line with the current range of analysts' expectations2."

 

Linden Homes

 

· £1,183m of sales reserved, contracted or completed of which £904m is for the current financial year to 30 June 2018 (2017: £1,176m and £915m, respectively).

· Sales rate of 0.71 per outlet per week since 1 January 2018 (2017: 0.74).

· Landbank of 11,750 plots (2017: 11,300). All plots secured for 2019 together with 77% of plots secured for 2020.

 

Partnerships & Regeneration

 

· £175m of sales reserved, contracted or completed of which £123m is for the current financial year to 30 June 2018 (2017: £127m and £77m, respectively).

· Contracting order book of £1.15bn (2017: £0.98bn).

· Landbank of 2,918 plots (2017: 2,867).

 

Construction

 

· Continued focus on risk management and cash.

· £3.3bn order book (2017: £3.5bn) with encouraging performance on current projects.

· 71% of next year's revenue secured (2017: 73%).

 

 

Conference call

 

A conference call for Analysts and Investors will be held at 08:30 am today (UK time)

 

UK Dial In: 0203 936 1888

International dial-in: Please access www.speakserve.com/numbers to access a full list of International numbers

Room Number: 603325

Participant PIN: 3109

 

 

 

For further enquiries please contact:

 

Galliford Try - Peter Truscott, Chief Executive 01895 855001

Graham Prothero, Finance Director

 

Tulchan Communications - James Macey White / Martin Pengelley / Elizabeth Snow 0207 353 4200

 

 

1. Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2017, the Group generated revenue of £2.8bn.

2. The range of analysts' forecasts with profit before tax after taking into account exceptional items for the year ending 30 June 2018 is £138m to £146m based on forecasts as at 17 May 2018.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFIAEFILFIT
Date   Source Headline
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20265:10 pmRNSTotal Voting Rights
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20254:20 pmRNSHolding(s) in Company
18th Dec 20254:20 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 202510:00 amRNSTotal Voting Rights
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20253:00 pmRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20254:00 pmRNSTransaction in Own Shares - Replacement
19th Nov 20254:00 pmRNSTransaction in Own Shares - Replacement
19th Nov 20254:00 pmRNSTransaction in Own Shares - Replacement
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20253:00 pmRNSResult of AGM
13th Nov 20257:00 amRNSAGM Statement
7th Nov 202510:00 amRNSDirector/PDMR Shareholding
3rd Nov 20254:15 pmRNSDirector/PDMR Shareholding
3rd Nov 202510:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.